487 filings
Page 2 of 25
6-K
v4ghr82
8 Dec 23
Report of Foreign Private Issuer
9:00am
6-K
1zb7kgx17yb6me7 oev
22 Nov 23
Report of Foreign Private Issuer
4:30pm
6-K
3lk65 7mz3tu2qdlerta
21 Nov 23
Report of Foreign Private Issuer
8:00am
6-K
of80e
31 Oct 23
Report of Foreign Private Issuer
4:30pm
6-K
mgg l3iry9vpbk
4 Oct 23
Notice of the Special General Meeting of Shareholders
9:00am
6-K
x8qmaccgtopous7wht
12 Sep 23
Report of Foreign Private Issuer
7:30am
6-K/A
w5iyn3u66b14
21 Aug 23
Current report (foreign) (amended)
7:31am
6-K
1ti sfolbpdwxyzq
28 Jul 23
Current Report
7:00am
6-K
okz8n3tyfgvfk08p9zv
26 Jul 23
Report of Foreign Private Issuer
9:00am
6-K
uwy0sf2yvx
11 Jul 23
Altamira Therapeutics Announces Pricing of $5.0 Million Public Offering
8:32am
424B4
7034vr2h
7 Jul 23
Prospectus supplement with pricing info
4:14pm
EFFECT
dhcf7heih01
6 Jul 23
Notice of effectiveness
12:15am
CORRESP
whjajwts1k1
5 Jul 23
Correspondence with SEC
12:00am
CORRESP
kxoca8hk
5 Jul 23
Correspondence with SEC
12:00am
6-K
5zfl6fakqw6w5yvgsdj
3 Jul 23
Report of Foreign Private Issuer
7:11pm
F-1/A
orw79xvfq0 hjlkef
3 Jul 23
Registration statement (foreign) (amended)
7:09pm
6-K
pwjglqbx f2
30 Jun 23
Report of Foreign Private Issuer
6:30am
6-K
5es admcr37pmslzjx80
27 Jun 23
Current Report
4:45pm
UPLOAD
svi1j0
23 Jun 23
Letter from SEC
12:00am
F-1
cfa6wp
16 Jun 23
Registration statement (foreign)
5:01pm